Product Portfolio

Vector borne diseases

Enabling local caregivers to better prepare for and respond to environmental changes and expanding vector populations

Increased global travel, expansion of large cities and changing climates are just a few of many factors that can impact the geographical distribution and incidence of disease carrying vectors, such as ticks and mosquitoes.

The emergence and spread of vector-borne diseases can pose a significant threat to local communities. However, globalization has enabled disease to spread further and more efficiently than ever before. In resource-limited countries, the lack of accessibility to reliable detection methods of vector-borne diseases aids to the transmission cascade. One method to help reduce the spread of infectious diseases is by implementing blood screening programs with state-of-the-art technologies that can detect life-threatening pathogens, ensuring that global blood supplies are safe before transfusion.

Roche offers a comprehensive assay menu to screen for a wide variety of vector-borne diseases including West Nile Virus (WNV), Babesiosis, Zika, Chagas, Chikungunya and Dengue fever. This portfolio runs on fully automated high-volume systems which offer the possibility to run laboratory developed tests to support the identification of emerging infections.

View products

Found 0 results in